Sustained Benefits for Belimumab Plus Standard of Care in SLE (CME/CE)

(MedPage Today) -- Longest SLE therapy study to date included patients on the intervention for up to 13 years
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care | Study